FIRST ASN HIGHLIGHTS& SEHA NEPHROPREVENTION CONFERENCE20

16

ADNEC • Abu Dhabi, UAE • Apr 1-2

Sponsorship Prospectus

ASN HIGHLIGHTS & SECOND SEHA NEPHROLOGY IN PRIMARY CARE CONFERENCE 20

17

Intercontinental Hotel • Abu Dhabi, UAE • Apr 14-15

CONFERENCEPROGRAM

2

WELCOMENOTES

Dear Colleagues,

On behalf of the American Society of Nephrology (ASN) and its nearly 16,000 members in more than 110 countries across the world, we would like to welcome you to the Abu Dhabi 2017 ASN Highlights & Second SEHA Nephrology in Primary Care Conference in partnership with the Abu Dhabi Health Services Company Nephrology and Kidney Disease Council (SEHA) and the Emirates Medical Association for Nephrology (EMAN).

ASN Highlights is a clinically focused educational opportunity that translates the highlights of ASN’s Annual Meeting, which is better known as Kidney Week, into practical advice with clinical relevance. The day will consist of expert speakers from the ASN Highlights team reviewing new developments in the following major areas of nephrology: glomerular diseases, transplantation, acute kidney injury, end-stage renal disease, hypertension, and general nephrology/chronic kidney diseases. The format is designed to help you incorporate the best of ASN Kidney Week 2016 into patient care. On the second day the ASN Highlights team will present on various topics at the Second SEHA Nephrology in Primary Care Conference.

We welcome you to these exciting educational programs.

Sincerely,

Mark E. Rosenberg, MD, FASNASN Councilor and Chair of the Education Committee

MESSAGE FROM THE CHAIRMEN

MESSAGE FROM THE ASN

Eleanor D. Lederer, MD, FASNASN President

Dear Colleagues,

In collaboration with American Society of Nephrology (ASN) it gives us great pleasure to welcome you to the 2017 ASN Highlights and Second SEHA Nephrology in Primary Care Conference in the Middle East. The conference is being hosted by SEHA, the Abu Dhabi Health Services Company Nephrology and Kidney Disease Council and is endorsed by Emirates Medical Association Nephrology Society (EMAN).

The conference presents key nephrology topics from the ASN Annual Meeting followed by more general topics on nephrology and chronic kidney disease.Through a culmination of collective efforts, an outstanding two-day program is prepared by reputable keynote speakers from the American Society of Nephrology. The program includes an exclusive one-day comprehensive program on ASN Highlights covering all major updates from the ASN Kidney Week 2016, which will provide the opportunity for specialists to learn about the latest updates.

Furthermore, the scientific program has been enriched with a one-day program targeting nephrology healthcare professionals who want to enhance their knowledge in nephrology.We are confident that this SEHA Conference will become a recurring annual event which is the fundamental way of advancing Nephrology education in the Middle East and beyond. We look forward to welcoming you to Abu Dhabi!

Sincerely,

Ali Abdulkareem AlObaidli, MD, FACPConference Chair

Samra Abouchacra, MD, FASNCo-Conference Chair

Mona Al-Rukhaimi, FRCP, FRCPEPresident, Emirates Medical Association Nephrology Society

3

ACKNOWLEDGMENT

The Organizing & Scientific Committee of the 2017 ASN Highlights and Second SEHA Nephrology in Primary Care Conference in the Middle East expresses its thanks and appreciation to all those who generously contributed to the success of the conference.

GOLD

EXHIBITORS

SUPPORTERS

4

SCIENTIFIC AND ORGANIZING COMMITTEEDr. Samra AbouchacraHead of CommitteeConsultant NephrologistTawam HospitalAl Ain, United Arab Emirates

Dr. George AbrahamMemberConsultant NephrologistAl Ain HospitalAl Ain, United Arab Emirates

Dr. Ayman Al MadaniMemberHead of Division, NephrologyMafraq HospitalAbu Dhabi, United Arab Emirates

Dr. Ali Abdulkareem Al ObaidliMemberChief Academic Affairs OfficerAbu Dhabi Health Services Company (SEHA)Abu Dhabi, United Arab Emirates

Dr. Zubaida AlismailiMemberSpecialist, PediatricsDeputy Chief Executive OfficerAbu Dhabi Health Services Company (SEHA)Abu Dhabi, United Arab Emirates

Dr. Mona AlrukhaimiMemberPresidentEmirates Medical Association Nephrology SocietyDubai, United Arab Emirates

Ms. Rizwana AltafMemberCorporate Senior Clinical Integration OfficerAbu Dhabi Health Services Company (SEHA)Abu Dhabi, United Arab Emirates

Dr. Bassam BerniehMemberConsultant NephrologistThe Heart Medical CenterAl Ain, United Arab Emirates

Dr. Hormaz DastoorMemberHead of Division, NephrologyAl Rahba HospitalAbu Dhabi, United Arab Emirates

Dr. Salah Eldin IssaMemberConsultant NephrologistMadinat Zayed HospitalAbu Dhabi, United Arab Emirates

Dr. Mohamad HassanMemberConsultant & Chief, NephrologySheikh Khalifa Medical CityAbu Dhabi, United Arab Emirates

Dr. Adel MohamediMemberConsultant NephrologistMadinat Zayed HospitalAbu Dhabi, United Arab Emirates

Dr. Nick RichardsMemberChief Executive & Medical OfficerAbu Dhabi Health Services Company (SEHA)Dialysis ServiceAbu Dhabi, United Arab Emirates

Dr. Abdelkarim SalehMemberDeputy Chief Medical OfficerSheikh Khalifa Medical CityAbu Dhabi, United Arab Emirates

Dr. Khaled TunaijiMemberConsultant NephrologistZayed Military HospitalAbu Dhabi, United Arab Emirates

5

TARGET AUDIENCE

• Nephrologists• Cardiologists• Diabetologists• Dieticians• Family Physicians• Internists• Medical Students• Nurses• Pathologists• Surgeons

CONFERENCE HIGHLIGHTS

• Glomerular Diseases• Transplantation• Acute Kidney Injury• End-Stage Renal Disease (ESRD)• Hypertension• General Nephrology & Chronic Kidney Disease• Nephroprevention, Targets and Management • Medications and the Kidney • Diabetic Nephropathy

CONFERENCE ORGANIZER

DiaEdu Management Consultancy

Phone: +971 4 453 2975Email: contact@diaedu.comWeb: www.diaedu.com

CONFERENCEINFORMATION

www.ASNHighlightsUAE.com

6

DELEGATEINFORMATIONACCREDITATION

The 2017 ASN Highlights and Second SEHA Nephrology in Primary Care Conference in the Middle East is granted with 9.0 CME Hours by by Health Authority - Abu Dhabi (HAAD)

SWIPING AT SESSION

Delegate certificates will reflect the number of hours attended. Please swipe your barcode once where indicated with a symbol in the program to ensure earning CME points.

HAAD CME CERTIFICATES

Upon releasing conference certificates, all attendees will be notified via the email used to register. This is expected within 2 weeks after the conference.

Kindly make sure your email is correct in the onsite system.

PRAYER ROOMS

The prayer room will be at El Waha which is at the same level of the lecture hall.

LUNCH

Lunch is served every day during the indicated hours in the scientific program in Liwa Majlis.

INQUIRIES

Diaedu officers will be available around the event venue area to provide assistance and answer any inquiries from delegates.

EMERGENCY CASES

In case of an emergency such as loss of valuables, finding items or requiring a paramedic please visit the information desks at the registration area.

PLEASE ENSURE YOU SWIPE ONCE UPON ENTRYTO HALL WHERE INDICATED WITH THE

SYMBOL IN THE PROGRAM.

7

SCIENTIFICPROGRAMSASN HIGHLIGHTS: APRIL 14, 2017

Time Session/Talk Speaker

08:00-09:00 Registration

09:00-09:30 Opening Ceremony

09:30-12:00 ASN Highlights Session IModerated by: Mark E. Rosenberg, Ali Abdulkareem Al Obaidli & Mona Alrukhaimi

09:30-10:15 Acute Kidney Injury Ravindra Mehta, MD

10:15-11:00 End-Stage Renal Disease Holly Kramer, MD, MPH

11:00-11:45 Gen & Chronic Kidney Disease Michael J. Choi, MD

11:45-12:00 Question and Answers

12:00-13:45 Lunch and Friday Prayer

13:45-16:30 ASN Highlights Session IIModerated by: Mark E. Rosenberg, Mohamad Hassan & Ali Alsahow

13:45-14:30 Glomerulonephritis James Tumlin, MD, CCRP

14:30-15:15 Hypertension Paul Drawz, MD

15:15-15:30 Break

15:30-16:15 Kidney Transplantation Alexander C. Wiseman, MD, FAST

16:15-16:30 Question and Answers

8

SCIENTIFICPROGRAMSNEPHROLOGY IN PRIMARY CARE: APRIL 15, 2017

Time Session/Talk Speaker

08:00-09:00 Registration

09:00-11:45 Nephrology in Primary Care Session I Moderated by: Ayman Al Madani & Bassam Bernieh

09:00-09:45 Obesity Related Renal Disease Holly Kramer, MD, MPH

09:45-10:30 Diabetes & CKD Advances in Management James Tumlin, MD, CCRP

10:30-10:45 Break

10:45-11:30 Renal Replacement Therapy on the Horizon Ravindra Mehta, MD

11:30-11:45 Question and Answers

11:45-13:00 Lunch Break

13:00-16:00 Nephrology in Primary Care Session IIModerated by: George Abraham & Adel Mohamedi

13:00-13:45 Diagnosis and Management of 2°/ resistant Hypertension Paul Drawz, MD

13:45-14:30 Management of transplant patient in Primary care Alexander C. Wiseman, MD, FAST

14:30-14:45 Break

14:45-15:30 Approach to Workup of Hematuria & Proteinuria Michael J. Choi, MD

15:30-16:00 Question and Answers

9

MICHAEL J. CHOI, MD, FNKF

CLINICAL DIRECTOR, NEPHROLOGY DIVISIONJOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINEBALTIMORE, MARYLAND, USA

FACULTYPROFILES

Dr. Choi is currently an Associate Professor of Medicine and Clinical Director of Nephrology at the Johns Hopkins University School of Medicine. He obtained his B.A. from Yale University. He received his medical degree and did his internal medicine residency training at Johns Hopkins. He was a nephrology fellow at the University of Pennsylvania. He is the President-Elect of the National Kidney Foundation. He was the Chair of the 2011 National Kidney Foundation Spring Clinical Meeting and he is the Vice Chair of Education for the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF KDOQI). He was co-editor of Chronic Kidney Disease for NephSAP and was the Clinical Nephrology team leader for the American Society of Nephrology Renal Weekends. He was the Deputy Editor for Advances in Chronic Kidney Disease and was an Associate Editor of Clinical Journal of the ASN, and Clinical Nephrology. He is Co-Editor of the Oxford Manual of Nephrology and Hypertension. His clinical and research interests include glomerular diseases, chronic kidney disease, and nephrolithiasis.

10

FACULTYPROFILES

ALEXANDER C. WISEMAN, MD, FAST

MEDICAL DIRECTOR, KIDNEY AND PANCREAS TRANSPLANT PROGRAMSUNIVERSITY OF COLORADO HOSPITALDENVER, COLORADO, USA

Dr. Wiseman is Medical Director of the Kidney and Pancreas Transplant Programs at the University of Colorado Hospital. Dr. Wiseman is a Professor of Medicine in the Division of Renal Diseases and Hypertension at the University of Colorado Health Sciences Center on the Anschutz Medical Campus. Dr. Wiseman completed both his undergraduate and medical school training at Washington University in St. Louis, followed by residency training in Internal Medicine at the University of California, San Francisco. He then completed fellowships in Nephrology and Transplant Nephrology at the University of Colorado Health Sciences Center. Dr. Wiseman is an active member of the American Society of Nephrology (ASN) and the American Society of Transplantation (AST). He is active in postgraduate and fellowship education for both societies, is an Associate Editor for the American Journal of Transplantation, and is on the American Society of Transplantation Board of Directors as a Councilor-at-Large. Dr. Wiseman’s academic interests include transplant therapies for diabetes, organ allocation and utilization, immunosuppressive strategies and emerging therapies. He has authored over 50 publications and 15 book chapters and has given over 100 invited lectures nationally and internationally.

11

PAUL DRAWZ, MD

ASSISTANT PROFESSOR OF MEDICINE, DIVISION OF RENAL DISEASES AND HYPERTENSIONUNIVERSITY OF MINNESOTAMINNESOTA, USA

FACULTYPROFILES

Dr. Drawz is an Assistant Professor of Medicine at the University of Minnesota. His research focuses on the relationship between kidney disease, ambulatory blood pressure, and adverse cardiovascular and renal outcomes. He was the lead author on the first ambulatory blood pressure manuscript from the Chronic Renal Insufficiency Cohort (CRIC) Study which described the increased risk for renal and cardiovascular target organ damage in patients with masked hypertension. He is the PI for the SPRINT Ambulatory Blood Pressure ancillary study, as well as the PI for the International Database of Ambulatory Blood Pressure in Renal Patients (I-DARE) coordinating center. Dr. Drawz graduated magna cum laude from Amherst College with a degree in sociology and received his medical degree from the University of Minnesota. He completed his internal medicine and nephrology training at Case Western Reserve University.

12

HOLLY KRAMER, MD, MPH

ASSOCIATE PROFESSOR OF PUBLIC HEALTH SCIENCES AND MEDICINE, DIVISION OF NEPHROLOGY AND HYPERTENSIONLOYOLA MEDICAL CENTERCHICAGO, USA

FACULTYPROFILES

Dr. Kramer is an Associate Professor of Public Health Sciences and Medicine in the Division of Nephrology and Hypertension. She is a practicing nephrologist and participates in both research and teaching. She is currently the Vice Chair of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (KDOQI) Commentaries and Controversies and has been involved with the KDOQI leadership since 2009. In 2016 she worked with KDOQI leadership to outline the controversies of utilizing ultrafiltration rate thresholds as a measure for dialysis quality. Dr. Kramer is very passionate about nutrition and its impact on health. Her past and current research focuses on the intersection between nutrition, kidney, and cardiovascular disease, and she has published several articles which identify obesity as a risk factor for kidney disease and its progression. Dr. Kramer graduated from Indiana University and completed Internal Medicine Residency at Emory University where she also served as Chief Medical Resident. She then completed her nephrology fellowship at the combined Massachusetts General Hospital and Brigham and Women’s Hospital in Boston, MA. She has completed research funded by the American Kidney Fund, Dialysis Clinic Incorporated, National Institutes of Health, and the National Kidney Foundation.

13

RAVINDRA MEHTA, MD, FASN

PROFESSOR EMERITUS OF MEDICINE, DEPARTMENT OF MEDICINEUNIVERSITY OF CALIFORNIA SAN DIEGOCALIFORNIA, USA

FACULTYPROFILES

Dr. Mehta is a Professor Emeritus of Medicine in the Department of Medicine at University of California San Diego where he directs the UCSD Masters in Clinical Research Program. He is an internationally recognized expert in the field of AKI. He holds a patent for “Continuous Hemodialysis Using Citrate.” He chairs the annual International CRRT Conference in San Diego that is now in its 22nd year. He chaired the ISN Committee on AKI and is a founding member of the Acute Dialysis Quality Initiative (ADQI) and the Acute Kidney Injury Network (AKIN). His research has informed the development of the RIFLE and AKIN diagnostic and staging criteria for AKI and development of KDIGO guidelines for AKI. He has been recognized as one of the Best Doctors in San Diego and the US for several years. In 2008 he was recognized by the American Nephrologists of Indian Origin, and in March 2009 he was elected as a Fellow of the Royal College of Physicians in the UK. He received the ISN Bywaters Award for lifetime achievement in AKI in April 2011. He has most recently been appointed as the Director of the ISN 0by25 initiative to eliminate preventable deaths from AKI by 2025. He has trained over 50 post-doctoral fellows, of whom 17 have carried out their research projects with him. He received the MBBS. degree (1976) from the Government Medical School in Amritsar, India, and the MD (1979) and DM (1981) degrees from the Post Graduate Institute of Medical Education and Research in Chandigarh, India. He subsequently completed a nephrology fellowship at the University of Rochester in Rochester, NY and obtained his boards in Internal Medicine (1986) and Nephrology (1988). He has been on the faculty at San Diego since 1988.

14

JAMES TUMLIN, MD

PROFESSOR, RENAL DIVISION, DIRECTORUNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE, SOUTHEAST RENAL RESEARCH INSTITUTETENNESSEE, USA

FACULTYPROFILES

Dr. James Tumlin currently serves as Professor in the renal division at the University of Tennessee College of Medicine and director of the Southeast Renal Research Institute. Dr. Tumlin received his medical degree from the University of South Florida and went on to complete a residency in internal medicine and a fellowship in nephrology at Emory University. He is boardcertified in internal medicine and research nephrology. Dr. Tumlin was then invited to join the Emory Faculty where excelled as a clinician and translational investigator. His laboratory was responsible for defining many of the physiologic roles of Calcineurin in the mammalian nephron. Dr. Tumlin left Emory at the Associate Professor level I 2005 where he then joined the faculty of the University of Tennessee College of Medicine While he has authored over 95 peer reviewed publications and is a nationally recognized expert in Lupus Nephritis and other forms of glomerular disease. Dr. Tumlin serves on the editorial boards for the Clinical Journal of the American Society of Nephrology and Journal of the American Society of Nephrology. He also serves as the associate editor for the Clinical Journal of the American Society of Nephrology. In addition to serving as president of the Medical Advisory Panel for the National Kidney Foundation of Georgia, he is a member of the American Medical Association, American College of Physicians, American Society of Nephrology, American Federation of Clinical Investigators, Southern Society of Clinical Investigation, International Society of Nephrology and Society of Clinical Research Associates (SOCRA). Dr. Tumlin is also the Founder and President of NephroNet; a non‐profit consortium of clinical investigators that are dedicated to advancing the field of nephrology through clinical research. Dr. Tumlin has lectured extensively at seminars and conferences, nationally as well as internationally, on dozens of topics including Apoptosis and Autoimmunity, acute kidney failure, radiocontrast nephropathy and lupus nephritis.

15

ABSTRACTSLISTINGSafety and Efficacy of Thromboembolic Prophylaxis in ESRD Patients on Regular HD Aysha Darwish Alkhemeiri1, Farida Mohammed AlMarzooqi1, Ahmed Chabaan1 1Tawam Hospital, Al Ain, United Arab Emirates

Cognitive Function Among Hemodialysis Patients in Saudi Arabia: An Observational Study Abdullah Hashim Almalki1, Majed Harthi1, Fatimah Binladen1, Abrar Zahrani1, Faisal Albluwi1, 1King Saudi Bin Badulaziz University, Jeddah, Saudi Arabia

Rituximab Associated Pneumocystis Jiroveii Pneumonia: A Rare Case Report Chandra Mauli Jha1, Hormaz Dara Dastoor 2, Samra Abouchacra3

1Gulf Diagnostic Center Hospital, Abu Dhabi, United Arab Emirates, 2Rahba Hospital, Abu Dhabi, United Arab Emirates, 3Tawam Hospital, Al Ain, United Arab Emirates

Polyuria in a Hyponatremic Patient: Residual Water Permeability: A Conceptual Explanation Hormaz Dara Dastoor1, Chandra Mauli Jha2, Samra Abouchacra3 1Rahba Hospital, Abu Dhabi, United Arab Emirates, 2Gulf Diagnostic Center Hospital, Abu Dhabi, United Arab Emirates, 3Tawam Hospital, Al Ain, United Arab Emirates

Hyponatremia: Proposed New Classification and Approach Based on Urine Osmolarity and Pathophysiology Chandra Mauli Jha1, Hormaz Dara Dastoor11, Samra Abouchacra3, , , 1Rahba Hospital, Abu Dhabi, United Arab Emirates, 2Gulf Diagnostic Centre Hospital, Abu Dhabi, United Arab Emirates, 3Tawam Hospital, Abu Dhabi, United Arab Emirates

Use of Logarithmic Constant of Exponential Decay to Control Sodium Conductivity and Kinetics in a Patient with End Stage Renal Disease and Severe Hyponatremia Hormaz Dara Dastoor1, Chandra Mauli Jha2, Samra Abouchacra3 1Rahba Hospital, Abu Dhabi, United Arab Emirates, 2Gulf Diagnostic Centre Hospital, Abu Dhabi, United Arab Emirates, 3Tawam Hospital, Al Ain, United Arab Emirates

Tacrolimus Bioavailability in Renal Transplant Patient Post Gastric Sleeve Surgery Khaled Karkout1, Fatima Al Kendi1, Ahmed Chabaan1, Yousef Boobes1

1Tawam Hospital, Al Ain, United Arab Emirates

Down the stony windpipe - a unique tale of extra-osseus calcification and dialysis vintageDhanya Mohan1, Zafer Husami1, Sima Abdolla1, Mohammed Railey1, Amna Khalifa Alhadari11Dubai Hospital, Dubai Health Authority, Dubai, United Arab Emirates

Green Coffee Bean Extract Attenuates Gentamicin Induced Acute Nephrotoxicity in RatsAmina Anwar Unis1, Amany Abdelbary2 1Ras al-Khaimah Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates, 2University of Alexandria, Alexandria, Egypt

WWW.ASNHIGHLIGHTSUAE.COM

DISCLAIMERThe relationship between the

official instutions endorsing this event and the sponsoring organizations of an event or

event-related item do not represent exclusive agree-ments between the institutions and the organization, nor do

they suggest that institutions endorse the programs, products or services of the organization.

RIGHT TO REFUSE SPONSORThe institutions reserve the right to reject a potential sponsor based on such factors as

questionable business practices, those with a mission in conflict with the mission of the institu-tions and those who desire unreasonable influence upon the event.

Copyright © 2007-2017 DiaEdu Management Consultancy, All Rights Reserved